From: Mapping EORTC QLQ-C30 onto EQ-5D for the assessment of cancer patients
 |  | Model 1a | Model 2b |
---|---|---|---|
Derivation set | Â | Â | Â |
Adjusted R2 | Â | 0.511 | 0.516 |
RMSE (% RMSE) | Â | 0.095 (8.1) | 0.095 (8.1) |
MAE (SD) | Â | 0.069 (0.065) | 0.069 (0.066) |
MAE > 0.05(%) | Â | 48.7 | 50.1 |
MAE > 0.1(%) | Â | 22.4 | 23.1 |
EQ-5D index | Actual | Predicted | Predicted |
Mean (SD) | 0.824 (0.137) | 0.823 (0.098) | 0.824 (0.098) |
Validation set | Â | Â | Â |
RMSE (% RMSE) | Â | 0.083 (7.1) | 0.085 (7.2) |
MAE (SD) | Â | 0.066 (0.052) | 0.066 (0.053) |
MAE > 0.05(%) | Â | 53.7 | 49.6 |
MAE > 0.1(%) | Â | 23.6 | 24.4 |
EQ-5D index | Actual | Predict | Predict |
Mean (SD) | 0.871 (0.113) | 0.873 (0.083) | 0.872 (0.085) |